The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning for anyone taking Ozempic, Wegovy, ...

It made the call for anyone suffering from a 'severe reaction' to GLP-1 medicine. According to the Government website, glucagon-like peptide-1 receptor agonists (GLP-1s) are medicines that help people ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning for anyone taking Ozempic, Wegovy, Rybelsus, or Mounjaro. The health body made the appeal on social media for anyone ...

Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...

But the results add to evidence from animal studies and reports that people are finding drugs like Ozempic and Wegovy helpful to manage cravings, not just for food, but also for tobacco and alcohol.

Novo Nordisk attempts to acquire weight-loss drug company Metsera during government shutdown, potentially avoiding FTC ...

Ozempic, Mounjaro and Wegovy are now cultural symbols of weight loss. These medications help control blood sugar and aid ...

Plus, the Trump administration is expected to release finalized Medicare payment rules for doctors and hospitals as soon as next week.

Wegovy Zepbound cost-effectiveness report finds both drugs remain valuable at higher prices despite affordability concerns, per ICER analysis.

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...